For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. That was the focus of a recent Medsider interview with Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, who discussed the company’s strategy to broaden access to robotic surgery through lower-cost technology, physician training and remote surgical capabilities.
Affordability and accessibility remain the company’s core priorities as it expands its surgical robotics platform globally, with artificial intelligence, automation, and new robotic platforms staying central to the long-term product roadmap. The SSi Mantra system was designed to reduce the cost of robotic surgery while supporting multiple specialties, including cardiac surgery, and has already been installed in more than 200 robotic systems worldwide. The company has completed over 11,700 robotic procedures, including more than 170 telesurgeries, demonstrating the viability of remote surgical support.
Telesurgery and teleproctoring are becoming important differentiators, allowing expert surgeons to support complex procedures remotely. This capability is particularly valuable in underserved regions where access to specialized surgeons is limited. Dr. Srivastava emphasized that rather than concentrating solely on competing with existing robotic surgery platforms, SS Innovations’ objective is to expand access to hospitals and patients that have historically been unable to adopt robotic surgery because of equipment costs and operating expenses.
The company is actively pursuing regulatory approvals from the U.S. Food and Drug Administration (FDA) and European authorities, while simultaneously expanding into additional international markets. These efforts align with a broader strategy to make robotic surgery more widely available, potentially transforming surgical care in both developed and developing countries. For further details on the company’s strategy and financial outlook, investors are directed to the full terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
Forward-looking statements in this article involve risks and uncertainties, including those set forth under “Risk Factors” in the company’s most recent Annual Report on Form 10-K and subsequent filings with the SEC. The company undertakes no duty to update this information unless required by law. The original release is available at www.newmediawire.com.
